Evaluation of a single-color-reading method for determining fructosamine

Area of Science:

• Clinical Chemistry
• Biochemical Diagnostics

Background:

• Fructosamine is a key indicator of glycemic control, reflecting average blood glucose levels over the preceding weeks.
• Accurate and reliable measurement of fructosamine is essential for managing diabetes and monitoring treatment efficacy.

Purpose of the Study:

• To evaluate the performance and suitability of a new commercial kit for determining serum and plasma fructosamine levels.
• To compare the results obtained with the new kit against established methods and assess its clinical applicability.

Main Methods:

• Evaluation of a commercial fructosamine assay kit.
• Determination of reference intervals using nondiabetic subjects.
• Comparison of results across different sample types (serum, EDTA-plasma, heparin-plasma, fluoride/oxalate-plasma).
• Assessment of precision (between-run CV), linearity, and interference from common blood constituents.

Main Results:

• The kit established a reference interval of 1.67 to 2.85 mmol/L (mean 2.17 mmol/L) in nondiabetic individuals.
• Equivalent fructosamine results were observed in serum and EDTA/heparin-anticoagulated plasma, with slightly lower values in fluoride/oxalate-treated plasma.
• The assay exhibited excellent precision (between-run CV < 4%) and linearity from 1.3 to 8.5 mmol/L.
• No significant interference was noted from tested blood constituents, although lipemic samples showed slightly increased values.
• Fructosamine levels correlated significantly with glycated hemoglobin, indicating good clinical correlation.

Conclusions:

• The evaluated commercial kit is a suitable and reliable alternative to the kinetic method for fructosamine determination.
• The kit demonstrates good analytical performance, making it appropriate for routine clinical laboratory use in assessing glycemic control.